Chronic Gonadotropin
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Cancer Genome Sequencing Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Genome Sequencing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Second Generation
1.2.3 Third Generation
1.3 Market by Application
1.3.1 Global Cancer Genome Sequencing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Treatment
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Genome Sequencing Market Perspective (2017-2028)
2.2 Cancer Genome Sequencing Growth Trends by Region
2.2.1 Cancer Genome Sequencing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Genome Sequencing Historic Market Size by Region (2017-2022)
2.2.3 Cancer Genome Sequencing Forecasted Market Size by Region (2023-2028)
2.3 Cancer Genome Sequencing Market Dynamics
2.3.1 Cancer Genome Sequencing Industry Trends
2.3.2 Cancer Genome Sequencing Market Drivers
2.3.3 Cancer Genome Sequencing Market Challenges
2.3.4 Cancer Genome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Genome Sequencing Players by Revenue
3.1.1 Global Top Cancer Genome Sequencing Players by Revenue (2017-2022)
3.1.2 Global Cancer Genome Sequencing Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Genome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Genome Sequencing Revenue
3.4 Global Cancer Genome Sequencing Market Concentration Ratio
3.4.1 Global Cancer Genome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Genome Sequencing Revenue in 2021
3.5 Cancer Genome Sequencing Key Players Head office and Area Served
3.6 Key Players Cancer Genome Sequencing Product Solution and Service
3.7 Date of Enter into Cancer Genome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genome Sequencing Breakdown Data by Type
4.1 Global Cancer Genome Sequencing Historic Market Size by Type (2017-2022)
4.2 Global Cancer Genome Sequencing Forecasted Market Size by Type (2023-2028)
5 Cancer Genome Sequencing Breakdown Data by Application
5.1 Global Cancer Genome Sequencing Historic Market Size by Application (2017-2022)
5.2 Global Cancer Genome Sequencing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Genome Sequencing Market Size (2017-2028)
6.2 North America Cancer Genome Sequencing Market Size by Country (2017-2022)
6.3 North America Cancer Genome Sequencing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Genome Sequencing Market Size (2017-2028)
7.2 Europe Cancer Genome Sequencing Market Size by Country (2017-2022)
7.3 Europe Cancer Genome Sequencing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Genome Sequencing Market Size (2017-2028)
8.2 Asia-Pacific Cancer Genome Sequencing Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Genome Sequencing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Genome Sequencing Market Size (2017-2028)
9.2 Latin America Cancer Genome Sequencing Market Size by Country (2017-2022)
9.3 Latin America Cancer Genome Sequencing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Genome Sequencing Market Size (2017-2028)
10.2 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Genome Sequencing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Cancer Genome Sequencing Introduction
11.1.4 Agilent Technologies Revenue in Cancer Genome Sequencing Business (2017-2022)
11.1.5 Agilent Technologies Recent Development
11.2 GE Healthcare Life Sciences
11.2.1 GE Healthcare Life Sciences Company Detail
11.2.2 GE Healthcare Life Sciences Business Overview
11.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Introduction
11.2.4 GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2017-2022)
11.2.5 GE Healthcare Life Sciences Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Cancer Genome Sequencing Introduction
11.3.4 Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2017-2022)
11.3.5 Johnson & Johnson Recent Development
11.4 LI-COR Biosciences
11.4.1 LI-COR Biosciences Company Detail
11.4.2 LI-COR Biosciences Business Overview
11.4.3 LI-COR Biosciences Cancer Genome Sequencing Introduction
11.4.4 LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022)
11.4.5 LI-COR Biosciences Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Detail
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Cancer Genome Sequencing Introduction
11.5.4 Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2017-2022)
11.5.5 Abbott Laboratories Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Detail
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Cancer Genome Sequencing Introduction
11.6.4 Beckman Coulter Revenue in Cancer Genome Sequencing Business (2017-2022)
11.6.5 Beckman Coulter Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Cancer Genome Sequencing Introduction
11.7.4 Bayer Revenue in Cancer Genome Sequencing Business (2017-2022)
11.7.5 Bayer Recent Development
11.8 Hamilton Thorne Biosciences
11.8.1 Hamilton Thorne Biosciences Company Detail
11.8.2 Hamilton Thorne Biosciences Business Overview
11.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Introduction
11.8.4 Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022)
11.8.5 Hamilton Thorne Biosciences Recent Development
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Detail
11.9.2 Integrated DNA Technologies Business Overview
11.9.3 Integrated DNA Technologies Cancer Genome Sequencing Introduction
11.9.4 Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2017-2022)
11.9.5 Integrated DNA Technologies Recent Development
11.10 Microchip Biotechnologies
11.10.1 Microchip Biotechnologies Company Detail
11.10.2 Microchip Biotechnologies Business Overview
11.10.3 Microchip Biotechnologies Cancer Genome Sequencing Introduction
11.10.4 Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2017-2022)
11.10.5 Microchip Biotechnologies Recent Development
11.11 Myriad Genetics
11.11.1 Myriad Genetics Company Detail
11.11.2 Myriad Genetics Business Overview
11.11.3 Myriad Genetics Cancer Genome Sequencing Introduction
11.11.4 Myriad Genetics Revenue in Cancer Genome Sequencing Business (2017-2022)
11.11.5 Myriad Genetics Recent Development
11.12 Commonwealth Biotechnologies
11.12.1 Commonwealth Biotechnologies Company Detail
11.12.2 Commonwealth Biotechnologies Business Overview
11.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Introduction
11.12.4 Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2017-2022)
11.12.5 Commonwealth Biotechnologies Recent Development
11.13 ZS Genetics
11.13.1 ZS Genetics Company Detail
11.13.2 ZS Genetics Business Overview
11.13.3 ZS Genetics Cancer Genome Sequencing Introduction
11.13.4 ZS Genetics Revenue in Cancer Genome Sequencing Business (2017-2022)
11.13.5 ZS Genetics Recent Development
11.14 Pacific Biosciences
11.14.1 Pacific Biosciences Company Detail
11.14.2 Pacific Biosciences Business Overview
11.14.3 Pacific Biosciences Cancer Genome Sequencing Introduction
11.14.4 Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022)
11.14.5 Pacific Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Genome Sequencing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Second Generation
Table 3. Key Players of Third Generation
Table 4. Global Cancer Genome Sequencing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cancer Genome Sequencing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Genome Sequencing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cancer Genome Sequencing Market Share by Region (2017-2022)
Table 8. Global Cancer Genome Sequencing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cancer Genome Sequencing Market Share by Region (2023-2028)
Table 10. Cancer Genome Sequencing Market Trends
Table 11. Cancer Genome Sequencing Market Drivers
Table 12. Cancer Genome Sequencing Market Challenges
Table 13. Cancer Genome Sequencing Market Restraints
Table 14. Global Cancer Genome Sequencing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cancer Genome Sequencing Market Share by Players (2017-2022)
Table 16. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2021)
Table 17. Ranking of Global Top Cancer Genome Sequencing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cancer Genome Sequencing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Genome Sequencing Product Solution and Service
Table 21. Date of Enter into Cancer Genome Sequencing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Genome Sequencing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cancer Genome Sequencing Revenue Market Share by Type (2017-2022)
Table 25. Global Cancer Genome Sequencing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cancer Genome Sequencing Revenue Market Share by Type (2023-2028)
Table 27. Global Cancer Genome Sequencing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cancer Genome Sequencing Revenue Market Share by Application (2017-2022)
Table 29. Global Cancer Genome Sequencing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cancer Genome Sequencing Revenue Market Share by Application (2023-2028)
Table 31. North America Cancer Genome Sequencing Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cancer Genome Sequencing Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cancer Genome Sequencing Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cancer Genome Sequencing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cancer Genome Sequencing Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cancer Genome Sequencing Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cancer Genome Sequencing Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cancer Genome Sequencing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Agilent Technologies Company Detail
Table 42. Agilent Technologies Business Overview
Table 43. Agilent Technologies Cancer Genome Sequencing Product
Table 44. Agilent Technologies Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 45. Agilent Technologies Recent Development
Table 46. GE Healthcare Life Sciences Company Detail
Table 47. GE Healthcare Life Sciences Business Overview
Table 48. GE Healthcare Life Sciences Cancer Genome Sequencing Product
Table 49. GE Healthcare Life Sciences Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 50. GE Healthcare Life Sciences Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Cancer Genome Sequencing Product
Table 54. Johnson & Johnson Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. LI-COR Biosciences Company Detail
Table 57. LI-COR Biosciences Business Overview
Table 58. LI-COR Biosciences Cancer Genome Sequencing Product
Table 59. LI-COR Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 60. LI-COR Biosciences Recent Development
Table 61. Abbott Laboratories Company Detail
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Cancer Genome Sequencing Product
Table 64. Abbott Laboratories Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Beckman Coulter Company Detail
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Cancer Genome Sequencing Product
Table 69. Beckman Coulter Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Cancer Genome Sequencing Product
Table 74. Bayer Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Hamilton Thorne Biosciences Company Detail
Table 77. Hamilton Thorne Biosciences Business Overview
Table 78. Hamilton Thorne Biosciences Cancer Genome Sequencing Product
Table 79. Hamilton Thorne Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 80. Hamilton Thorne Biosciences Recent Development
Table 81. Integrated DNA Technologies Company Detail
Table 82. Integrated DNA Technologies Business Overview
Table 83. Integrated DNA Technologies Cancer Genome Sequencing Product
Table 84. Integrated DNA Technologies Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 85. Integrated DNA Technologies Recent Development
Table 86. Microchip Biotechnologies Company Detail
Table 87. Microchip Biotechnologies Business Overview
Table 88. Microchip Biotechnologies Cancer Genome Sequencing Product
Table 89. Microchip Biotechnologies Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 90. Microchip Biotechnologies Recent Development
Table 91. Myriad Genetics Company Detail
Table 92. Myriad Genetics Business Overview
Table 93. Myriad Genetics Cancer Genome SequencingProduct
Table 94. Myriad Genetics Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 95. Myriad Genetics Recent Development
Table 96. Commonwealth Biotechnologies Company Detail
Table 97. Commonwealth Biotechnologies Business Overview
Table 98. Commonwealth Biotechnologies Cancer Genome SequencingProduct
Table 99. Commonwealth Biotechnologies Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 100. Commonwealth Biotechnologies Recent Development
Table 101. ZS Genetics Company Detail
Table 102. ZS Genetics Business Overview
Table 103. ZS Genetics Cancer Genome SequencingProduct
Table 104. ZS Genetics Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 105. ZS Genetics Recent Development
Table 106. Pacific Biosciences Company Detail
Table 107. Pacific Biosciences Business Overview
Table 108. Pacific Biosciences Cancer Genome SequencingProduct
Table 109. Pacific Biosciences Revenue in Cancer Genome Sequencing Business (2017-2022) & (US$ Million)
Table 110. Pacific Biosciences Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Genome Sequencing Market Share by Type: 2021 VS 2028
Figure 2. Second Generation Features
Figure 3. Third Generation Features
Figure 4. Global Cancer Genome Sequencing Market Share by Application in 2021 & 2028
Figure 5. Treatment Case Studies
Figure 6. Research Case Studies
Figure 7. Cancer Genome Sequencing Report Years Considered
Figure 8. Global Cancer Genome Sequencing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Cancer Genome Sequencing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cancer Genome Sequencing Market Share by Region: 2021 VS 2028
Figure 11. Global Cancer Genome Sequencing Market Share by Players in 2021
Figure 12. Global Top Cancer Genome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genome Sequencing as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2021
Figure 14. North America Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Cancer Genome Sequencing Market Share by Country (2017-2028)
Figure 16. United States Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Cancer Genome Sequencing Market Share by Country (2017-2028)
Figure 20. Germany Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cancer Genome Sequencing Market Share by Region (2017-2028)
Figure 28. China Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Cancer Genome Sequencing Market Share by Country (2017-2028)
Figure 36. Mexico Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Cancer Genome Sequencing Market Share by Country (2017-2028)
Figure 40. Turkey Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Cancer Genome Sequencing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Agilent Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 43. GE Healthcare Life Sciences Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 44. Johnson & Johnson Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 45. LI-COR Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 46. Abbott Laboratories Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 47. Beckman Coulter Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 48. Bayer Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 49. Hamilton Thorne Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 50. Integrated DNA Technologies Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 51. Microchip Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 52. Myriad Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 53. Commonwealth Biotechnologies Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 54. ZS Genetics Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 55. Pacific Biosciences Revenue Growth Rate in Cancer Genome Sequencing Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies GE Healthcare Life Sciences Johnson & Johnson LI-COR Biosciences Abbott Laboratories Beckman Coulter Bayer Hamilton Thorne Biosciences Integrated DNA Technologies Microchip Biotechnologies Myriad Genetics Commonwealth Biotechnologies ZS Genetics Pacific Biosciences